Bortenat Injection

Bortenat Injection is recommended for treating blood cancer like mantle cell lymphoma and multiple mueloma. This injection contains protesomes protein that has significant role in retarding proliferation of cancer affected cells. Approved by FDA, this pharmaceutical product is available in 2 mg and 3.5 mg quantity based options. Patients suffering from kidney disorder, liver complications, diabetes and inadequate white or red blood cells need to take precaution prior to using this injection. Bortenat Injection needs to be taken only after consulting with medical practitioner. This injection should be stored under 30 degree C temperature. Long lasting effectiveness is one of its key features.